Leukemia
Reports from the United States describe recent advances in leukemia research
Published in Cancer Weekly, October 17th, 2006
Study 1: Researchers proposed the feasibility of treating chronic lymphocytic leukemia (CLL) by clofarabine on a weekly schedule.
"Based on its mechanistic similarity to fludarabine and cladribine and the success of these analogues for treatment of CLL, we hypothesized that clofarabine would be effective for indolent leukemias. The present study was conducted to determine the efficacy and cellular pharmacology during clinical trials of single-agent clofarabine in CLL," scientists in the United States reported.
"Previously treated patients with relapsed/refractory CLL...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-10-17)
More Articles from Cancer Weekly
- Bladder Cancer
Bladder cancer recurrence risk predicted by E-cadherin promoter polymorphism - Breast Cancer
Breast cancer growth stimulated by Essiac and Flor-Essence herbal tonics - Cancer Incidence
Increased cancer incidence not associated with fluvastatin treatment - Colorectal Cancer
Colorectal cancer progression predicted by sarco/endoplasmic reticulum calcium-ATPase 2 expression - Spinal Bone Metastases
Spinal bone metastases survival prediction model developed and validated - Acute Myeloid Leukemia
Acute myeloid leukemia-associated MLL partial tandem duplications persist lifelong - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
